224 related articles for article (PubMed ID: 31647346)
1. Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study.
Palaia I; Di Donato V; Musella A; Di Pinto A; Santangelo G; Petriglia G; Benedetti Panici P
J Invest Surg; 2021 Jun; 34(6):672-676. PubMed ID: 31647346
[TBL] [Abstract][Full Text] [Related]
2. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
[TBL] [Abstract][Full Text] [Related]
3.
Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
[TBL] [Abstract][Full Text] [Related]
4. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
Kim YN; Lee D; Cha J; Kang WJ; Lee YJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Gynecol Oncol; 2022 Sep; 166(3):438-443. PubMed ID: 35907682
[TBL] [Abstract][Full Text] [Related]
5. Complementary role of 18F-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis.
Taşkin S; Varli B; Ersöz CC; Altin D; Soydal Ç; Ortaç F
Nucl Med Commun; 2020 Apr; 41(4):389-394. PubMed ID: 31939903
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
Tanaka T; Terai Y; Yamamoto K; Yamada T; Ohmichi M
Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772
[TBL] [Abstract][Full Text] [Related]
7. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
[TBL] [Abstract][Full Text] [Related]
8. The Combination of Preoperative Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Mapping in the Surgical Management of Endometrioid Endometrial Cancer.
Bese T; Sal V; Demirkiran F; Kahramanoglu I; Tokgozoglu N; Ilvan S; Aydin O; Hallac M; Vatankulu B; Demirayak G; Turan H; Arvas M
Int J Gynecol Cancer; 2016 Sep; 26(7):1228-38. PubMed ID: 27643647
[TBL] [Abstract][Full Text] [Related]
9. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
Park JY; Lee JJ; Choi HJ; Song IH; Sung CO; Kim HO; Chae SY; Kim YT; Nam JH
Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer.
De Nardi P; Guarneri G; Canevari C; Tamburini A; Slim N; Passoni P; Rosati R
Colorectal Dis; 2019 Sep; 21(9):1017-1024. PubMed ID: 31077550
[TBL] [Abstract][Full Text] [Related]
11. Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
Stewart KI; Chasen B; Erwin W; Fleming N; Westin SN; Dioun S; Frumovitz M; Ramirez PT; Lu KH; Wong F; Aloia TA; Soliman PT
Cancer; 2019 Oct; 125(19):3347-3353. PubMed ID: 31225906
[TBL] [Abstract][Full Text] [Related]
12. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
13. Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial.
Wagner LM; Kremer N; Gelfand MJ; Sharp SE; Turpin BK; Nagarajan R; Tiao GM; Pressey JG; Yin J; Dasgupta R
Cancer; 2017 Jan; 123(1):155-160. PubMed ID: 27563842
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.
Pritchard KI; Julian JA; Holloway CM; McCready D; Gulenchyn KY; George R; Hodgson N; Lovrics P; Perera F; Elavathil L; O'Malley FP; Down N; Bodurtha A; Shelley W; Levine MN
J Clin Oncol; 2012 Apr; 30(12):1274-9. PubMed ID: 22393089
[TBL] [Abstract][Full Text] [Related]
15. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
[TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging of endometrial sentinel lymph nodes utilizing fluorescent-labeled Tilmanocept during robotic-assisted surgery in a porcine model.
Anderson KM; Barback CV; Qin Z; Hall DJ; Hoh CK; Vera DR; McHale MT
PLoS One; 2018; 13(7):e0197842. PubMed ID: 29965996
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
Sponholtz SE; Mogensen O; Hildebrandt MG; Schledermann D; Parner E; Markauskas A; Frøding LP; Fuglsang K; Vilstrup MH; Bjørnholt SM; Jensen PT
Gynecol Oncol; 2021 Sep; 162(3):546-554. PubMed ID: 34226018
[TBL] [Abstract][Full Text] [Related]
19. Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study.
Bjørnholt SM; Mogensen O; Bouchelouche K; Sponholtz SE; Parner ET; Hildebrandt MG; Loft A; Neumann G; Bjørn SF; Dahl K; Markauskas A; Frøding LP; Jensen PT
Gynecol Oncol; 2024 Mar; 182():179-187. PubMed ID: 38335900
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Kuwano H
Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
